Point of View: The challenges faced by living stock collections in the USA

  1. Kevin McCluskey
  2. Kyria Boundy-Mills
  3. Greg Dye
  4. Erin Ehmke
  5. Gregg F Gunnell
  6. Hippokratis Kiaris
  7. Maxi Polihronakis Richmond
  8. Anne D Yoder
  9. Daniel R Zeigler
  10. Sarah Zehr
  11. Erich Grotewold  Is a corresponding author
  1. Fungal Genetics Stock Center, Kansas State University, United States
  2. University of California, Davis, United States
  3. Duke University, United States
  4. University of South Carolina, United States
  5. University of California, San Diego, United States
  6. The Ohio State University, United States

Abstract

Many discoveries in the life sciences have been made using material from living stock collections. These collections provide a uniform and stable supply of living organisms and related materials that enhance the reproducibility of research and minimize the need for repetitive calibration. While collections differ in many ways, they all require expertise in maintaining living organisms and good logistical systems for keeping track of stocks and fulfilling requests for specimens. Here, we review some of the contributions made by living stock collections to research across all branches of the tree of life, and outline the challenges they face.

https://doi.org/10.7554/eLife.24611.001

Introduction

The goals of living stock collections are to preserve the genetic diversity of target organisms, to maintain research materials, and make these resources available to researchers around the world. Living stock collections are distinct from other bio-repositories, such as natural history museums (Rocha et al., 2014) and biobanks (Baker, 2012), because the resources they contain are generally capable of being multiplied and propagated. This creates unique challenges for long-term sustainability.

The collections are typically housed within stock centers, seed banks, vivariums and botanical gardens, which are usually based at a university or other research institution. Collections make their resources available in a number of ways: these include distributing resources to qualified researchers, providing access to materials at the collection for specific experiments, and the sharing of detailed historical information regarding each organism or strain.

Living collections have been identified as the foundation of the emerging bioeconomy (OECD, 2001) and they significantly increase the impact of shared research materials (Furman and Stern, 2011). By allowing access to identical strains, cultivars and cell lines, the collections allow published research to be directly reproduced. This is of special value because – along with addressing concerns about the reproducibility of scientific data – it also makes individual organisms, clones, populations or tools that have been used successfully in research studies available to other investigators, bypassing the need for repeated optimization studies.

Living collections are funded by a number of mechanisms. In the United States, for example, the Department of Agriculture Agricultural Research Service (USDA-ARS) supports several centers that conserve and distribute germplasm of agricultural importance. Similarly, the National Institutes of Health (NIH) maintains diverse collections of animal models of human disease such as rodents, swine, axoltls and primates. Finally, the National Science Foundation (NSF) has supported diverse living genetic and biodiversity collections for over 50 years through a competitive program now called Collections in Support of Biological Research (CSBR).

The global research and development community values living collections as demonstrated by recent progress in the development of networks to create a global microbial research commons (Dedeurwaerdere, 2010; Uhlir, 2011). These efforts are bearing fruit in the number of growing networks, consortia and even international treaties on access to genetic resources. The ratification and activation of the Nagoya Protocol on Access and Benefit Sharing in 2014 (Dedeurwaerdere et al., 2012), and of the International Treaty on Plant Genetic Resources for Food and Agriculture in 2004 (Mekouar, 2002), has required that research and development consider the place of origin in sourcing research materials. Living collections are key partners in ensuring that materials are ethically and legally procured (Boundy-Mills et al., 2016).

Our focus here is on open living research collections in the USA that are funded by a combination of competitive grants and community user fees (Table 1). Many of these collections were assembled over multiple decades and would be difficult or impossible to replace. We emphasize that these resource centers are essential for the long-term maintenance of key living resources for research and scientific replication and as such they are highly vulnerable to policy and funding changes. This creates dangerous uncertainty for the communities affected.

Table 1

A selection of public living research collections in the USA.

https://doi.org/10.7554/eLife.24611.002
Collection nameAcronymHoldingsHostSupport
Microbial collections
American Type Culture CollectionATCC18,000 bacterial and 7,600 fungal type strainsATCCUsers, government contracts
BEI ResourcesBEI13,000 strains and reagents for emerging pathogen researchATCCNIAID
Fungal Genetics Stock CenterFGSC25,000 filamentous fungi including mutants, genetic testers, wild strains,
plasmids and mutant sets
Kansas State UniversityNSF (1961–2014), KSU, user fees
Phaff Yeast Culture CollectionUCDFST7,500 wild-type yeastUniversity of California, DavisUC, NSF, user fees
E. coli Genetic Stock CenterCGSC8,000 mutant and wild K12 E. coliYale UniversityNSF, user fees
Bacillus Genetic Stock CenterBGSC2,600 mutant and wild Bacillus subtilisThe Ohio State UniversityNSF, user fees
International Culture Collection of (Vesicular) Arbuscular Mycorrhizal FungiINVAM1,112 vesicular arbuscular mycorrhizal fungiWest Virginia UniversityNSF, user fees
World Phytophthora CollectionWPC10,000 wild oomycete fungiUniversity of California, RiversideUCR
USDA ARS Culture CollectionNRRL95,000 agricultural and industrial fungi and bacteriaUSDA National Center for Agricultural Utilization ResearchUSDA
USDA ARS Collection of Entomopathogenic Fungal CulturesARSEF13,000 fungal culturesUSDA Robert W. Holley Center CenterUSDA
UTEX Culture Collection of AlgaeUTEX3,000 freshwater algaeUniversity of Texas, AustinNSF, user fees
National Center for Marine Algae and MicrobiotaNCMA2,800 algal cultures, viral and bacterial associatesBigelow Laboratory for Ocean SciencesNSF, user fees
The Chlamydomonas Resource CenterChlamy4,000 mutant and wild type strainsUniversity of MinnesotaNSF, user fees
Animal and cell line collections
Bloomington Drosophila Stock CenterBDSCOver 50,000 Drosophila genetic stocksIndiana UniversityNIH, user fees, HHMI
Duke Lemur CenterDLC250 living and 4,000 historic individual Strepsirrhine primates, with a biosample bank of >10,000 samplesDuke UniversityNSF, user fees
Drosophila Species Stock CenterDSSCFliesUniversity of California San DiegoNSF, user fees
Jackson LaboratoriesJAXMiceJackson LabsUser fees
Peromyscus Genetic Stock CenterPGSCAt least 4 species and several coat color and behavioral mutants of deer miceUniversity of South CarolinaNSF, user fees
Plant collections and seed banks
Arabidopsis Biological Resource CenterABRC~1 million Seeds and DNA StocksThe Ohio State UniversityNSF, user fees
Maize Genetics Cooperation Stock CenterMGCSCOver 100,000 maize variantsUniversity of Illinois, Urbana/ChampaignUSDA-ARS
National Plant Germplasm SystemNPGS576,991 Plant accessionsDistributed around the US and backed up at the USDA NLGRP in Ft. CollinsUSDA-ARS

If the centers that harbor these collections cease to exist, or even if their operations must be reduced below a certain critical threshold, the negative consequences to the scientific community are unavoidable. For example, without stock centers there is an increased risk of researchers using inauthentic materials (such as contaminated or improperly identified stocks), research communities may become more exclusive, and it may cost more to generate key strains, clones, lines or varieties. Ultimately, this makes it harder for researchers to reproduce key results (Sheppard, 2013).

Impact of living collections on research

Living collections impact research at many different levels. At the most basic level, they provide the biological resources for fundamental studies. In one high profile example, the repeat sequences now called CRISPR were first observed in a phosphatase mutant strain of Escherichia coli (Ishino et al., 1987) generated in a mutant screen that used strains from the E. coli Genetic Stock Center, which is supported by the NSF (Nakata et al., 1978). Similarly, the first experiments to demonstrate the polymerase chain reaction were conducted using an enzyme isolated from a thermophilic bacterium that had been deposited into the American Type Culture Collection almost twenty years earlier (Mullis et al., 1986). The Penicillium strain that has been used for large-scale antibiotic production since the mid-1940’s (supplanting the original Fleming strain) was isolated and shared through the USDA NRRL collection (Raper et al., 1944), therein launching the modern era of antibiotics.

Living collections are important for national security and have been used in many situations including the 2001 Anthrax attacks (Kurtzman, 2011) as well as to identify the source of infection in an outbreak of the eye disease ocular keratitis (Short et al., 2011). Similarly, through identifying pathogenic organisms associated with agriculture, and breeding for resistance to emerging plant and animal pathogens, living collections are foundational for food security. And, because they are central resources for student projects and often repositories of protocols and technical expertise, living collections help train new generations of students to be researchers and scientists.

Living collections also provide an invaluable resource to help solve the irreproducibility problem that is plaguing the scientific literature (Sheppard, 2013). For example, stock centers have been identified as key players in ensuring the integrity and identity of natural isolates or ecotypes (Anastasio et al., 2011) and in providing quality controlled lines for biomedical research (Stacey, 2000). Living collections also help to ensure that plant genetic resources are preserved and accessed ethically (McCouch et al., 2013), and the Convention on Biological Diversity has identified them as the appropriate means for us to preserve and benefit from microbial biodiversity.

Living collections capture an important, yet minor fraction of extant biodiversity

Historically, living collections have generally focused on organisms that serve research communities of significant sizes, often corresponding to model systems that have been broadly embraced by the community (e.g., E. coli, Neurospora crassa and Arabidopsis thaliana). In some cases, such as certain fruit fly species in the genus Drosophila, the stock center is the only source of these stocks as they can no longer be collected in the wild.

The ability to culture microorganisms previously believed to be ‘unculturable’ [see for example (Browne et al., 2016)], combined with using genomics information to validate taxonomy and genetic properties, is increasing the number of new strains being deposited in living collections around the world (Boundy-Mills et al., 2015). Nevertheless, these collections continue to capture only a tiny fraction of the existing biodiversity, and this is likely to continue to be the case in the future.

For many purposes, the possibility to bank and distribute genomic DNA provides a simpler and less expensive alternative to storing the whole organism, although microbial type and patent strains need to be preserved alive to satisfy taxonomic or treaty obligations. For larger organisms, such as plants, it is often necessary to develop specific practices for each species. For example, the procedures used to grow and preserve seeds of the model plant A. thaliana would not be suitable for maize or other cereal crops.

Challenges to maintaining collection integrity

Collecting, preserving and making reference material available to the community requires living collections to maintain very strict quality control standards, regarding not only the viability of the stock, but also their identity and authenticity. Viability and purity checks have been an integral part of quality control at most stock centers for many years. Animal cell lines have suffered many problems with misidentification of stocks and contamination (Hughes et al., 2007), which is forcing the community to develop stringent standards for cell line authentication (Almeida et al., 2016). Stocks used to be identified on the basis of morphology and phenotype, which are affected by the way in which the organism’s genes interact with the environment. However, the advent of easily accessible genomics tools has forced research communities and the corresponding living collections to shift to performing genotyping analyses, which are often significantly more time consuming, expensive and require specialized personnel.

More difficult to detect, but equally important, are instances of spontaneous mutations that arise as a consequence of key stocks that are used as references by the community being continuously replicated. This can lead to the stock changing so much that it is no longer a true reference. The plant community has been particularly vocal about this problem, developing a set of best practices to be implemented by researchers and stock centers to avoid it (Bergelson et al., 2016). Similarly, microbe collections reduce genetic drift by using techniques such as freeze drying and cryopreservation that preserve material in suspended animation and these practices are fundamental to published best practice guidelines (Wiest et al., 2012).

Materials in collections are usually deposited by independent researchers and may be exchanged between stock centers, which generates additional challenges in controlling the authenticity and equivalency of the stocks. The microorganism community has partially solved this problem through the introduction of StrainInfo, a strain passport that captures all the exchange history of the stock, as well an overview of the strain in an uniform format (Verslyppe et al., 2014). To what extent a similar data integration and tracking system could be adopted by other communities is not clear, although a persistent uniform resource identifier would help deal with this issue.

Research in the absence of living collections

While the impact of living collections has been amply demonstrated (Furman and Stern, 2011), not all research communities have the benefit of open collections. Although Saccharomyces has been a major research system with high impact – including results that have produced several Nobel prizes in recent years – stocks have been maintained without a formal centrally-managed yeast culture collection for many years.

The Yeast Genetic Stock Center collection, operated for several decades by R. Mortimer (Mortimer and Johnston, 1986), was donated to the American Type Culture Collection (ATCC) in 1998 and most gene deletion sets have been managed by commercial vendors. Most yeast strains and related materials were shared on a peer-to-peer, ad-hoc basis where individual investigators were free to limit distribution, creating a closed community that further complicates research reproducibility and open science. Moreover, the detailed breeding records maintained for decadal mammal collections give investigators assurance that the interpretation of data will not be inadvertently conflated by genetic relatedness.

Many research systems have dedicated living repositories and some enjoy significant economies of scale. Mice from the Jackson Laboratories, genetic stocks of Drosophila melanogaster from the Bloomington Stock Center, and diverse animal models of human disease are available from either commercial or publicly supported collections. Most microbe and biodiversity related resources do not have this scale, and as such are relegated to a more modest level of support, often driven by the initiative and efforts of the collection staff. While the research systems supported by these smaller biological resource centers have made tremendous impact over the decades, the collections face increasing challenges that threaten the ability of the community to access diverse research systems effectively.

In the absence of open collections with their established quality management, researchers must resort to obtaining materials from colleagues or isolating similar organisms directly from nature, thereby running the risk that the materials are not identical across studies. The adage, “apples to apples” refers to direct comparisons, but to stretch the metaphor, it could be more accurately described as “Red Delicious apples to Red Delicious apples.” Otherwise the risk is that comparisons are on the order of “Granny Smith apples to Crab apples,” which, to the apple pie chef, is bound to yield disappointing results. Without this high degree of specificity, the ability to accurately produce comparable results across studies is diminished.

The challenges ahead

The outcome of reduced support for living stock collections is disproportionately borne by small institutions, students and researchers in areas not tied to human health or other research systems with high economic impact (Mccluskey, 2017). By way of contrast, even modest support for living collections pays dividends to public, academic and scientific communities in many different ways.

Collections have both the capacity and the obligation to reflect developments in biological inquiry. Long-term support for collections can ensure that historical materials from one era are available to generate technological advances in the next generation, thereby enabling answers to research questions that were not envisioned when the materials were first collected, characterized and preserved. Open collections ensure the availability of such resources by implementing proven approaches to managing stocks – including modern resources such as plasmids and gene deletion mutants – and by developing novel culture methods to bring historically nonculturable organisms into the mainstream. With good quality and data management strategies they can also ensure that the associated information is standardized, easily retrievable and sharable with users, as is being done for the microbiology community (Verslyppe et al., 2010; Wu et al., 2016).

The NSF has funded living collections over many years and, as a direct consequence of their reporting requirements, the collections they support have longstanding quality management practices as well as robust data on the use of material and its impact, collection growth and sustainability. Accordingly, NSF-supported collections have long histories of implementing best practices (Wiest et al., 2012) that ensure access to high quality resources. USA federal support requires that collections maintain detailed records, a formal community advisory board evaluates each collection’s holdings and practices, and that the collections share resources without regard to personal preference, historical relationship, or even institutional affiliation. Living public collections “level the playing field” and allow equal access to valuable, well-documented materials. Coincidently, funding agencies also benefit from supporting living collections given that the collections are natural partners in material management plans.

With the input of formal advisory boards, living stock collections speak on behalf of their research communities and are therefore placed in the uniquely awkward position of having to advocate for their own continuance. Shared metrics, such as a pseudo h-index that records the number of citations to publications generated via use of the collection, are useful in communicating the value and impact of living collections. Several living collections have pseudo h-indices on the scale of 60–125. Other collections have too many citations to use available h-index calculations. For example, the ATCC is cited over 600,000 times in the Google Scholar database, and the USDA Agricultural Research Service NRRL culture collection has documented over 49,000 citations that directly work with strains in the collection.

These measures are imperfect and a quantitative mechanism to document how resources in living collections are used might be a powerful mechanism for further establishing the value of federal investment in these collections. A global identifier for research resources such as strains, cultivated varieties, cell lines and animals would be a valuable first step in this process (Wu et al., 2016). In addition, adopting policies similar to those employed recently to authenticate cultured cell lines could also be applied.

While the International Code of Nomenclature of Algae, Fungi and Plants (McNeill et al., 2012) requirement that new type strains be deposited in at least three public collections in at least two countries is a good model, the number of modified strains used in public research would overtax the capacity of present collections. This notwithstanding, the authentication of specimens’ identity through available records of living collections could be considered sufficient to the extent that the collection follows best practices for living collections and biobanks. This also argues that living collections seek and obtain external certifications, such as those available through the International Standards Organization (ISO) or the Good Laboratory Practice as described by the Organization for Economic Cooperation and Development.

Another complicating factor that living collections face is the non-uniformity in resource ownership, which has several facets. First, different agencies have different ownership standards. For example, USDA collections are all owned by the USDA, and most NIH collections are owned by the NIH. Conversely, collections that receive NSF support are owned by their host institutions, or are maintained and distributed on behalf of the donor. While many collections consider that their resources are in the public domain, they are more accurately held in trust for the public (Uhlir, 2011).

Second, most living collections in the USA have been assembled over many years, often several decades, and little attention has been given to formal transfer of intellectual property rights. Modern collections require both material accession agreements and, for subsequent distributions, material transfer agreements (MTAs). These agreements typically limit both rights and liabilities and can assume a variety of levels of rigor, ranging from implied, to “click-through”, to formal. For example, the Addgene plasmid collection has been assembled with intellectual property management at the forefront, simplifying subsequent distribution of resources (Kamens, 2015; Kamens, 2014). European microbe collections, united by the European Culture Collection Organization, embrace the TRUST code of conduct – which addresses both MTA issues as well as compliance with the Nagoya Protocol on Access and Benefit Sharing.

USA culture collections addressed the question of how to ensure compliance at an NSF-sponsored meeting in February. This meeting was open to collaborators from every domain of life, and included participants from natural history collections, as well as living research and biodiversity collections (http://www.usccn.org/Pages/USCCN_Nagoya_2017.aspx). As exemplified by the engagement at this meeting, staff at living collections are at the forefront of ensuring that ethical practices are followed in obtaining and distributing living resources. Importantly, the participants heard from the USA National Focal Point for the Nagoya Protocol that the USA does not restrict access to germplasm, although certain landowners or managers, such as the US National Park System, may have their own requirements for accessing genetic resources.

Additional presentations at the meeting emphasized that each party to the Nagoya Protocol is required to establish their own national legislation on Access and Benefit Sharing. Brazil and the EU have the most mature legislation, accessed via the Convention on Biological Diversity Access and Benefit Sharing Clearing-House (ABSCH, https://absch.cbd.int/). The highly divergent perspectives on what constitutes “access” emphasize that researchers should consult the ABSCH prior to using genetic resources (or information) with an origin outside their own country.

Forward directions

Living collections benefit from public support to ensure that valuable resources for research in every area of biology are available to future generations of scientists (Mccluskey, 2017). While some medical and agricultural collections receive public funds, many public biodiversity and genetics collections do not. Without this external support, the collections managers have no alternative but to recover the costs of collection maintenance by raising user fees. While this simple approach is appealing, it creates a scenario where only well-funded laboratories can afford to obtain validated materials.

To ensure that the materials generated by today’s research investment are available to future generations of scientists, living collections need basic financial support including salaries and subsidies on end-user fees. Living collections will benefit substantially if journal editors and granting agencies enact and enforce requirements that materials described in publications be available from public repositories, just as gene and genome sequences are required to be deposited in and distributed by public data repositories. Requiring capacity building beyond simply preserving the materials from the past will allow preservation and documentation of the large numbers of deposits generated by the requirement that living resources be available from public sources. Standing on the shoulders of giants is made easier by access to shared materials. The availability of authentic and diverse materials from published research empowers all investigators, regardless of their career stage or funding status.

References

  1. Book
    1. Kurtzman CP
    (2011)
    The Agricultural Research Service Culture Collection: Germplasm Accessions and Research Programs
    In: Uhlir P. F, editors. Designing the Microbial Research Commons: Proceedings of an International Symposium. Washington DC: National Academies Press. ISBN 978-0-309-21982-2. pp. 55–62.
    1. McNeill J
    2. Barrie F
    3. Buck W
    4. Demoulin V
    5. Greuter W
    6. Hawksworth D
    7. Herendeen P
    8. Knapp S
    9. Marhold K
    10. Prado J
    (2012)
    International code of nomenclature for algae, fungi, and plants (Melbourne code)
    Regnum Vegetabile 154:208.
  2. Book
    1. Mekouar A
    (2002)
    A Global Instrument on Agrobiodiversity: The International Treaty on Plant Genetic Resources for Food and Agriculture
    Food and Agriculture Organization of the United Nations (FAO). Legal Office.
    1. Mortimer RK
    2. Johnston JR
    (1986)
    Genealogy of principal strains of the yeast genetic stock center
    Genetics 113:35–43.
    1. Nakata A
    2. Yamaguchi M
    3. Izutani K
    4. Amemura M
    (1978)
    Escherichia coli mutants deficient in the production of alkaline phosphatase isozymes
    Journal of Bacteriology 134:287–294.
  3. Book
    1. OECD
    (2001)
    Biological Resource Centres – Underpinning the Future of Life Sciences and Biotechnology
     Wald S. , editors. Paris, France:  Organisation for Economic Development and Cooperation:.
    1. Raper KB
    2. Alexander DF
    3. Coghill RD
    (1944)
    Penicillin: ii. natural variation and penicillin production in Penicillium notatum and allied Species 1, 2
    Journal of Bacteriology 48:639.
  4. Book
    1. Uhlir PF
    (2011)
    Designing the Microbial Research Commons: Proceedings of an International Workshop
    Washington, D.C: National Academies Press.

Decision letter

  1. Sarah Shailes
    Reviewing Editor; eLife, United Kingdom

In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article "Public living collections and their role in biological research: Impact, challenges, and expectations" for consideration by eLife. Your article has been reviewed by two peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Peter Rodgers as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Paul De Vos (Reviewer #2).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary: The manuscript describes the important role of living stock collections in scientific research, underlining the major challenges that they face today.

Although the manuscript deals with a very important issue in biological research, the reviewers feel that there are some aspects that could be discussed in more detail to make the manuscript more valuable to the research community and improve the arguments for continued support of public living stock collections.

Essential revisions:

1) The importance and the necessity of financial support is mentioned too often in several different paragraphs. This gives the impression that the manuscript was written to promote the collections in order to ask for money (public money). Please cut, or at least revise, most of the sentences related to financial support and rewrite the manuscript accordingly.

2) The reviewers consider living collections to be indispensable as accessible references for taxonomic (hence identification) purposes. Please expand the discussion on this topic, including a reflection on the present situation about the coverage of the complete biodiversity.

More information from reviewer #2: "Preserving and making reference material available also imposes a very strict quality control (QC) on the viability and the authenticity of living stock cultures/collections that are maintained/preserved. One must realize that this QC is crucial and that a correct application of the implemented QC system is key for the operational value of the whole system. Indeed, living stocks are subjected to genetic drifting during their preservation period. If the cultures are used for taxonomic references, the taxonomic markers are usually stable enough for identification above the strain/specimen level. However, when markers are used for identification at or even below the strain level (isolate/specimen level) the reference strains may have undergone genetic changes that make them no longer suited as references for identification, or in those cases where the living stocks are used in certified test in e.g. pharmaceutical context."

3) Although the problem of integration of data is mentioned in the manuscript, it is not discussed deeply enough to underpin the lack of interest for the situation along with the lack of financial support.

More information from reviewer #2: "Researchers often exchange material in collections (mostly for free). In many cases, neither the donating nor the receiving party have the skills or the attitude to control the authenticity of the material that is exchanged resulting in the use of non-equivalent material for their research. This means that the results of cumulative research must be treated with a degree of criticism. Live stocks are also exchanged between collections and in this cases an important number of discrepancies of various nature are reported. If researchers plan to integrate data from different collections several controls need to be introduced as has been demonstrated by the various papers of the strainInfo team (Van Brabant B, Gray T, Verslyppe B, Kyrpides N, Dietrich K, Glockner FO, Cole J, Farris R, Schriml LM, De Vos P, De Baets B, Field D, Dawyndt P. 2008. Laying the foundation for a Genomic Rosetta Stone: creating information hubs through the use of consensus identifiers. IOMICS 12:123-127. Verslyppe, B., De Smet, W., De Baets, B., De Vos, P., Dawyndt, P. (2011). Make Histri: Reconstructing the exchange history of bacterial and archaeal type strains. Syst Appl Microbiol 34: 328-336. Verslyppe, B., De Smet, W., De Baets, B., De Vos, P., Dawyndt, P. (2014). StrainInfo introduces electronic passports for microorganisms. Syst. Appl. Microbiol. 37(1): 42-50 etc.)"

4) Include more in-depth discussion of some of the ethical issues surround living collections:

Often the research has been supported by public money and hence the data belong to the public domain. However, protective actions are seldom undertaken to prevent this data being used for private, commercialized applications. Although the international community tried to take care of this problem via treatments and conventions (CBD, Nagoya protocol). Unfortunately, these conventions are not recognized by all governments on the globe and are more like a burden.

Only about 10-15% of the biological material that has been the subject of research is available via public collections. It is clear that from a scientific viewpoint, this is unacceptable and should be of major concern.

https://doi.org/10.7554/eLife.24611.004

Author response

Essential revisions:

1) The importance and the necessity of financial support is mentioned too often in several different paragraphs. This gives the impression that the manuscript was written to promote the collections in order to ask for money (public money). Please cut, or at least revise, most of the sentences related to financial support and rewrite the manuscript accordingly.

We eliminated most of the instances in which the manuscript promoted the collections as if asking for public funds, and modified the text accordingly. However, funding remains one of the challenges, hence it deserves to be mentioned.

2) The reviewers consider living collections to be indispensable as accessible references for taxonomic (hence identification) purposes. Please expand the discussion on this topic, including a reflection on the present situation about the coverage of the complete biodiversity.

More information from reviewer #2: "Preserving and making reference material available also imposes a very strict quality control (QC) on the viability and the authenticity of living stock cultures/collections that are maintained/preserved. One must realize that this QC is crucial and that a correct application of the implemented QC system is key for the operational value of the whole system. Indeed, living stocks are subjected to genetic drifting during their preservation period. If the cultures are used for taxonomic references, the taxonomic markers are usually stable enough for identification above the strain/specimen level. However, when markers are used for identification at or even below the strain level (isolate/specimen level) the reference strains may have undergone genetic changes that make them no longer suited as references for identification, or in those cases where the living stocks are used in certified test in e.g. pharmaceutical context."

To address the first part of the comment by the reviewer, we added a new short section entitled “Living Collections Capture an Important, Yet Minor Fraction of Extant Biodiversity”. To address the issue of quality control and collection integrity, we added a second short new section entitled “Challenges to Maintaining Collection Integrity”.

3) Although the problem of integration of data is mentioned in the manuscript, it is not discussed deeply enough to underpin the lack of interest for the situation along with the lack of financial support.

More information from reviewer #2: "Researchers often exchange material in collections (mostly for free). In many cases, neither the donating nor the receiving party have the skills or the attitude to control the authenticity of the material that is exchanged resulting in the use of non-equivalent material for their research. This means that the results of cumulative research must be treated with a degree of criticism. Live stocks are also exchanged between collections and in this cases an important number of discrepancies of various nature are reported. If researchers plan to integrate data from different collections several controls need to be introduced as has been demonstrated by the various papers of the strainInfo team (Van Brabant B, Gray T, Verslyppe B, Kyrpides N, Dietrich K, Glockner FO, Cole J, Farris R, Schriml LM, De Vos P, De Baets B, Field D, Dawyndt P. 2008. Laying the foundation for a Genomic Rosetta Stone: creating information hubs through the use of consensus identifiers. IOMICS 12:123-127. Verslyppe, B., De Smet, W., De Baets, B., De Vos, P., Dawyndt, P. (2011). Make Histri: Reconstructing the exchange history of bacterial and archaeal type strains. Syst Appl Microbiol 34: 328-336. Verslyppe, B., De Smet, W., De Baets, B., De Vos, P., Dawyndt, P. (2014). StrainInfo introduces electronic passports for microorganisms. Syst. Appl. Microbiol. 37(1): 42-50 etc.)"

The revised manuscript includes the following paragraph as part of the newly added “Challenges to Maintaining Collection Integrity” section: “Materials in collections are usually deposited by independent researchers and may be exchanged between stock centers, generating additional challenges in controlling the authenticity and equivalency of the stocks. […] To what extent a similar data integration and tracking system that follows each stock can be adopted by other communities is unclear, although a persistent uniform resource identifier would help deal with this issue.”

4) Include more in-depth discussion of some of the ethical issues surround living collections:

Often the research has been supported by public money and hence the data belong to the public domain. However, protective actions are seldom undertaken to prevent this data being used for private, commercialized applications. Although the international community tried to take care of this problem via treatments and conventions (CBD, Nagoya protocol). Unfortunately, these conventions are not recognized by all governments on the globe and are more like a burden.

Only about 10-15% of the biological material that has been the subject of research is available via public collections. It is clear that from a scientific viewpoint, this is unacceptable and should be of major concern.

We don't think that this is necessarily an issue that can be discussed constructively in this perspective for the following reasons: 1) Depending on the funding source and the community that each center serves, there is a wide range of ethical issues associated with the stocks that the centers in which the authors are involved distribute. 2) The perspective does address the issue of MTAs, and MTAs do address the issue of how stocks should be used. 3) The discussion of how public domain research his being used for profit by industry is one that goes way beyond the issues that this centers are involved with.

https://doi.org/10.7554/eLife.24611.005

Article and author information

Author details

  1. Kevin McCluskey

    Department of Plant Pathology, Fungal Genetics Stock Center, Kansas State University, Manhattan, United States
    Contribution
    KM, Writing—original draft, Writing—review and editing
    Competing interests
    The authors declare that no competing interests exist.
  2. Kyria Boundy-Mills

    Phaff Yeast Culture Collection, Food Science and Technology, University of California, Davis, Davis, United States
    Contribution
    KB-M, Writing—original draft, Writing—review and editing
    Competing interests
    The authors declare that no competing interests exist.
  3. Greg Dye

    Duke Lemur Center, Duke University, Durham, United States
    Contribution
    GD, Writing—original draft, Writing—review and editing
    Competing interests
    The authors declare that no competing interests exist.
  4. Erin Ehmke

    Duke Lemur Center, Duke University, Durham, United States
    Contribution
    EE, Writing—original draft, Writing—review and editing
    Competing interests
    The authors declare that no competing interests exist.
  5. Gregg F Gunnell

    Duke Lemur Center, Duke University, Durham, United States
    Contribution
    GFG, Writing—original draft, Writing—review and editing
    Competing interests
    The authors declare that no competing interests exist.
  6. Hippokratis Kiaris

    Department of Drug Discovery and Biomedical Sciences and Peromyscus Genetic Stock Center, University of South Carolina, Columbia, United States
    Contribution
    HK, Writing—original draft, Writing—review and editing
    Competing interests
    The authors declare that no competing interests exist.
  7. Maxi Polihronakis Richmond

    Drosophila Species Stock Center, University of California, San Diego, San Diego, United States
    Contribution
    MPR, Writing—original draft, Writing—review and editing
    Competing interests
    The authors declare that no competing interests exist.
  8. Anne D Yoder

    Duke Lemur Center, Duke University, Durham, United States
    Contribution
    ADY, Writing—original draft, Writing—review and editing
    Competing interests
    The authors declare that no competing interests exist.
  9. Daniel R Zeigler

    Bacillus Genetics Stock Center, The Ohio State University, Columbus, United States
    Contribution
    DRZ, Writing—review and editing
    Competing interests
    The authors declare that no competing interests exist.
  10. Sarah Zehr

    Duke Lemur Center, Duke University, Durham, United States
    Contribution
    SZ, Writing—original draft, Writing—review and editing
    Competing interests
    The authors declare that no competing interests exist.
  11. Erich Grotewold

    Arabidopsis Biological Resource Center, The Ohio State University, Columbus, United States
    Contribution
    EG, Writing—original draft, Writing—review and editing
    For correspondence
    Grotewold.1@osu.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4720-7290

Funding

National Science Foundation (DBI-1534564)

  • Kevin McCluskey

National Science Foundation (DBI-1351502)

  • Maxi Polihronakis Richmond

National Science Foundation (DBI-1642534)

  • Anne D Yoder

National Science Foundation (DBI-1561691)

  • Anne D Yoder

National Science Foundation (DBI-1561210)

  • Erich Grotewold

National Science Foundation (DBI-1349230)

  • Hippokratis Kiaris

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Acknowledgements

Many of the ideas presented here were formalized during an NSF-supported workshop on the power of biological infrastructure to advance knowledge (DBI-1642534 to ADY). This is DLC publication number 1343. This is contribution 17-233-J from the Kansas Agricultural Experiment Station.

Publication history

  1. Received:
  2. Accepted:
  3. Accepted Manuscript published:
  4. Accepted Manuscript updated:
  5. Version of Record published:

Copyright

© 2017, McCluskey et al.

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,417
    views
  • 277
    downloads
  • 7
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Kevin McCluskey
  2. Kyria Boundy-Mills
  3. Greg Dye
  4. Erin Ehmke
  5. Gregg F Gunnell
  6. Hippokratis Kiaris
  7. Maxi Polihronakis Richmond
  8. Anne D Yoder
  9. Daniel R Zeigler
  10. Sarah Zehr
  11. Erich Grotewold
(2017)
Point of View: The challenges faced by living stock collections in the USA
eLife 6:e24611.
https://doi.org/10.7554/eLife.24611
  1. Further reading

Further reading

    1. Medicine
    2. Microbiology and Infectious Disease
    Berit Siedentop, Viacheslav N Kachalov ... Sebastian Bonhoeffer
    Research Article

    Background:

    Under which conditions antibiotic combination therapy decelerates rather than accelerates resistance evolution is not well understood. We examined the effect of combining antibiotics on within-patient resistance development across various bacterial pathogens and antibiotics.

    Methods:

    We searched CENTRAL, EMBASE, and PubMed for (quasi)-randomised controlled trials (RCTs) published from database inception to 24 November 2022. Trials comparing antibiotic treatments with different numbers of antibiotics were included. Patients were considered to have acquired resistance if, at the follow-up culture, a resistant bacterium (as defined by the study authors) was detected that had not been present in the baseline culture. We combined results using a random effects model and performed meta-regression and stratified analyses. The trials’ risk of bias was assessed with the Cochrane tool.

    Results:

    42 trials were eligible and 29, including 5054 patients, qualified for statistical analysis. In most trials, resistance development was not the primary outcome and studies lacked power. The combined odds ratio for the acquisition of resistance comparing the group with the higher number of antibiotics with the comparison group was 1.23 (95% CI 0.68–2.25), with substantial between-study heterogeneity (I2=77%). We identified tentative evidence for potential beneficial or detrimental effects of antibiotic combination therapy for specific pathogens or medical conditions.

    Conclusions:

    The evidence for combining a higher number of antibiotics compared to fewer from RCTs is scarce and overall compatible with both benefit or harm. Trials powered to detect differences in resistance development or well-designed observational studies are required to clarify the impact of combination therapy on resistance.

    Funding:

    Support from the Swiss National Science Foundation (grant 310030B_176401 (SB, BS, CW), grant 32FP30-174281 (ME), grant 324730_207957 (RDK)) and from the National Institute of Allergy and Infectious Diseases (NIAID, cooperative agreement AI069924 (ME)) is gratefully acknowledged.

    1. Evolutionary Biology
    2. Microbiology and Infectious Disease
    Vera Vollenweider, Karoline Rehm ... Rolf Kümmerli
    Research Article

    The global rise of antibiotic resistance calls for new drugs against bacterial pathogens. A common approach is to search for natural compounds deployed by microbes to inhibit competitors. Here, we show that the iron-chelating pyoverdines, siderophores produced by environmental Pseudomonas spp., have strong antibacterial properties by inducing iron starvation and growth arrest in pathogens. A screen of 320 natural Pseudomonas isolates used against 12 human pathogens uncovered several pyoverdines with particularly high antibacterial properties and distinct chemical characteristics. The most potent pyoverdine effectively reduced growth of the pathogens Acinetobacter baumannii, Klebsiella pneumoniae, and Staphylococcus aureus in a concentration- and iron-dependent manner. Pyoverdine increased survival of infected Galleria mellonella host larvae and showed low toxicity for the host, mammalian cell lines, and erythrocytes. Furthermore, experimental evolution of pathogens combined with whole-genome sequencing revealed limited resistance evolution compared to an antibiotic. Thus, pyoverdines from environmental strains have the potential to become a new class of sustainable antibacterials against specific human pathogens.